Results of general meeting
Zarara shareholders are advised that the ordinary resolution proposed at the
general meeting of Zarara held on Monday, 24 December 2001 was passed.
Accordingly, the acquisition, as a going concern, of the lysine
manufacturing business of the partnership between AECI Limited ("AECI") and
the Industrial Development Corporation of South Africa Limited ("IDC") and
the acquisition of the entire issued share capital of and the claims which
AECI and the IDC may have against AECI Bioproducts, have been approved by
Zarara shareholders. The only outstanding condition precedent to the
acquisition is the approval by the Competition Authorities.
Illovo
27 December 2001
Corporate advisor and sponsor
Brait
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
